3M CO MMM
NYSE · XNYS · stock · Surgical & Medical Instruments & Apparatus
Chart by TradingView
5/9
Piotroski F — financial health
5.46
Altman Z″ — distress risk · safe
48.1%
Dividend payout · moderate
Financials (annual, from 10-K)
| FY | Revenue | Net income | Gross profit | Free cash flow | Equity |
|---|---|---|---|---|---|
| 2025 | $24.9B | $3.2B | — | $1.4B | $4.7B |
| 2024 | $24.6B | $4.2B | — | $638.0M | $3.9B |
| 2023 | $24.6B | -$7.0B | — | $5.1B | $4.9B |
| 2022 | $26.2B | $5.8B | — | $3.8B | $14.8B |
| 2021 | $35.4B | $5.9B | — | $5.9B | $15.1B |
| 2020 | $32.2B | $5.4B | — | $6.6B | $12.9B |
Why these scores methodology →
Piotroski F-score: 5/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: 5.46 (safe)
- Working capital / assets 0.18
- Retained earnings / assets 1.014
- EBIT / assets 0.123
- Equity / liabilities 0.143
Source: SEC EDGAR filings · CIK 0000066740 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.